ZNF585B
gene geneOn this page
Also known as FLJ14928SZFP41Zfp27
Summary
ZNF585B (zinc finger protein 585B, HGNC:30948) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 585B (Q52M93). May be involved in transcriptional regulation.
Predicted to enable zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 92285 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 109 total
- MANE Select transcript:
NM_152279
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30948 |
| Approved symbol | ZNF585B |
| Name | zinc finger protein 585B |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14928, SZFP41, Zfp27 |
| Ensembl gene | ENSG00000245680 |
| Ensembl biotype | protein_coding |
| Entrez | 92285 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 6 protein_coding, 4 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000392156, ENST00000526705, ENST00000527838, ENST00000531805, ENST00000532828, ENST00000534363, ENST00000586320, ENST00000591273, ENST00000591492, ENST00000905951, ENST00000905952, ENST00000965087
RefSeq mRNA: 1 — MANE Select: NM_152279
NM_152279
CCDS: CCDS12500
Canonical transcript exons
ENST00000532828 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002174128 | 37210441 | 37210536 |
| ENSE00002956745 | 37181579 | 37187244 |
| ENSE00003472336 | 37189661 | 37189753 |
| ENSE00003536243 | 37207040 | 37207254 |
| ENSE00003557476 | 37190024 | 37190150 |
Expression profiles
Bgee: expression breadth ubiquitous, 219 present calls, max score 84.27.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.5750 / max 86.1217, expressed in 1438 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180708 | 4.5750 | 1438 |
Top tissues by expression
272 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 84.27 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.51 | gold quality |
| colonic epithelium | UBERON:0000397 | 82.70 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.48 | gold quality |
| oocyte | CL:0000023 | 81.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.59 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.55 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 80.45 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.36 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.25 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.21 | gold quality |
| pituitary gland | UBERON:0000007 | 80.12 | gold quality |
| thyroid gland | UBERON:0002046 | 79.96 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 79.93 | gold quality |
| left ovary | UBERON:0002119 | 79.70 | gold quality |
| apex of heart | UBERON:0002098 | 79.65 | gold quality |
| adenohypophysis | UBERON:0002196 | 79.52 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 79.33 | gold quality |
| mucosa of stomach | UBERON:0001199 | 79.18 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 79.05 | gold quality |
| lower esophagus | UBERON:0013473 | 79.03 | gold quality |
| body of uterus | UBERON:0009853 | 79.01 | gold quality |
| corpus callosum | UBERON:0002336 | 78.87 | gold quality |
| cerebellum | UBERON:0002037 | 78.80 | gold quality |
| right ovary | UBERON:0002118 | 78.80 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 78.60 | gold quality |
| endocervix | UBERON:0000458 | 78.57 | gold quality |
| rectum | UBERON:0001052 | 78.57 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.52 | gold quality |
| cortical plate | UBERON:0005343 | 78.49 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.95 |
| E-MTAB-7249 | no | 322.70 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
100 targeting ZNF585B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 585B — Q52M93 (reviewed: Q52M93)
Alternative names: zinc finger protein 41-like protein
All UniProt accessions (7): E9PNT4, E9PQ00, Q52M93, F2Z3L4, K7EL12, K7EP93, K7EPG8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_689492* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (27 total): zinc finger region 21, chain 1, domain 1, region of interest 1, compositionally biased region 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q52M93-F1 | 75.39 | 0.03 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 76 (showing top):
TGCGCANK_UNKNOWN, NRF2_01, CETS1P54_01, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, RAO_BOUND_BY_SALL4, CSR_EARLY_UP.V1_DN, CBX7_TARGET_GENES, CIITA_TARGET_GENES, FOXJ2_TARGET_GENES, IRF5_TARGET_GENES, KLF7_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), developmental process (GO:0032502), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (2): zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| biological_process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
388 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF585B | OR4D6 | Q8NGJ1 | 451 |
| ZNF585B | GXYLT1 | Q4G148 | 415 |
| ZNF585B | BEAN1 | Q3B7T3 | 321 |
| ZNF585B | MRPL55 | Q7Z7F7 | 320 |
| ZNF585B | ERICH1 | Q86X53 | 311 |
| ZNF585B | SP140L | Q9H930 | 307 |
| ZNF585B | ZBTB3 | Q9H5J0 | 302 |
| ZNF585B | NOL8 | Q76FK4 | 300 |
| ZNF585B | ZBTB25 | P24278 | 294 |
| ZNF585B | LHFPL3 | Q86UP9 | 290 |
| ZNF585B | C1orf52 | Q8N6N3 | 290 |
| ZNF585B | COG5 | Q9UP83 | 280 |
| ZNF585B | RERGL | Q9H628 | 270 |
| ZNF585B | INO80E | Q8NBZ0 | 270 |
| ZNF585B | ZNF385B | Q569K4 | 269 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF585B | PCK1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Mecom | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF585B | hflC | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF585B | RIC8A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): ZNF585B (Affinity Capture-MS), RIC8A (Two-hybrid), ZNF585B (Affinity Capture-RNA), PCK1 (Affinity Capture-MS), ZNF585B (Affinity Capture-MS), ZNF585B (Co-fractionation), ZNF585B (Affinity Capture-MS)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
109 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 92 |
| Likely benign | 11 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1128 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:37190018:GCTTA:G | donor_loss | 1.0000 |
| 19:37190019:CTTAC:C | donor_loss | 1.0000 |
| 19:37190020:TTA:T | donor_loss | 1.0000 |
| 19:37190022:A:AT | donor_loss | 1.0000 |
| 19:37190023:C:A | donor_loss | 1.0000 |
| 19:37190023:CCTA:C | donor_gain | 1.0000 |
| 19:37190026:A:AC | donor_gain | 1.0000 |
| 19:37190027:C:CC | donor_gain | 1.0000 |
| 19:37210485:T:TA | donor_gain | 1.0000 |
| 19:37210412:A:AC | donor_gain | 0.9900 |
| 19:37210413:C:CC | donor_gain | 0.9900 |
| 19:37210483:AGT:A | donor_gain | 0.9900 |
| 19:37187263:A:T | acceptor_gain | 0.9800 |
| 19:37190022:A:AC | donor_gain | 0.9800 |
| 19:37190023:C:CC | donor_gain | 0.9800 |
| 19:37207178:G:C | donor_gain | 0.9800 |
| 19:37210405:A:AC | donor_gain | 0.9800 |
| 19:37210460:T:TA | donor_gain | 0.9800 |
| 19:37210523:T:TA | donor_gain | 0.9800 |
| 19:37190152:T:G | acceptor_loss | 0.9700 |
| 19:37190153:G:C | acceptor_loss | 0.9700 |
| 19:37210373:C:CT | donor_gain | 0.9700 |
| 19:37210409:CTGA:C | donor_gain | 0.9700 |
| 19:37210489:G:T | donor_gain | 0.9700 |
| 19:37190149:CC:C | acceptor_gain | 0.9600 |
| 19:37190150:CC:C | acceptor_gain | 0.9600 |
| 19:37207251:GAACC:G | acceptor_loss | 0.9600 |
| 19:37207252:AACCT:A | acceptor_loss | 0.9600 |
| 19:37207253:ACCT:A | acceptor_loss | 0.9600 |
| 19:37207254:CCTAG:C | acceptor_loss | 0.9600 |
AlphaMissense
5110 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:37185524:A:C | F671L | 0.998 |
| 19:37185524:A:T | F671L | 0.998 |
| 19:37185526:A:G | F671L | 0.998 |
| 19:37185860:G:C | F559L | 0.998 |
| 19:37185860:G:T | F559L | 0.998 |
| 19:37185862:A:G | F559L | 0.998 |
| 19:37185944:A:C | F531L | 0.998 |
| 19:37185944:A:T | F531L | 0.998 |
| 19:37185946:A:G | F531L | 0.998 |
| 19:37186028:G:C | F503L | 0.997 |
| 19:37186028:G:T | F503L | 0.997 |
| 19:37186030:A:G | F503L | 0.997 |
| 19:37185356:A:C | F727L | 0.996 |
| 19:37185356:A:T | F727L | 0.996 |
| 19:37185358:A:G | F727L | 0.996 |
| 19:37185608:A:C | F643L | 0.996 |
| 19:37185608:A:T | F643L | 0.996 |
| 19:37185610:A:G | F643L | 0.996 |
| 19:37185771:C:G | R589P | 0.996 |
| 19:37185776:G:C | F587L | 0.996 |
| 19:37185776:G:T | F587L | 0.996 |
| 19:37185778:A:G | F587L | 0.996 |
| 19:37186112:G:C | F475L | 0.996 |
| 19:37186112:G:T | F475L | 0.996 |
| 19:37186114:A:G | F475L | 0.996 |
| 19:37185440:G:C | F699L | 0.995 |
| 19:37185440:G:T | F699L | 0.995 |
| 19:37185442:A:G | F699L | 0.995 |
| 19:37185692:A:C | F615L | 0.995 |
| 19:37185692:A:T | F615L | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000047061 (19:37195425 C>T), RS1000340447 (19:37183438 G>A,T), RS1000450952 (19:37190488 G>C), RS1000470024 (19:37190785 C>T), RS1000501323 (19:37190571 T>C,G), RS1000590677 (19:37196906 A>C,G), RS1000622238 (19:37195689 T>C), RS1000647071 (19:37203023 A>G), RS1000666358 (19:37189257 C>T), RS1000696364 (19:37202729 G>A), RS1000738952 (19:37190764 C>T), RS1001137949 (19:37201670 A>G), RS1001187740 (19:37188932 GTTC>G), RS1001226366 (19:37183218 T>C), RS1001235688 (19:37190089 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_406 | Obesity-related traits | 5.000000e-06 |
| GCST007387_24 | Insomnia symptoms (never/rarely vs. sometimes/usually) | 5.000000e-08 |
| GCST007388_16 | Insomnia symptoms (never/rarely vs. usually) | 8.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003939 | energy intake |
| EFO:0007876 | insomnia measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| Air Pollutants | increases expression, affects expression, increases abundance | 2 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| terbufos | increases methylation | 1 |
| tobacco tar | decreases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | increases expression, affects cotreatment | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Methotrexate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Parathion | increases methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD31 | HEK293 eGFP-ZNF585B | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.